Apellis Pharmaceuticals I...

NASDAQ: APLS · Real-Time Price · USD
18.32
-0.51 (-2.71%)
At close: Jun 16, 2025, 3:59 PM
18.30
-0.11%
After-hours: Jun 16, 2025, 04:04 PM EDT

Apellis Pharmaceuticals Revenue

Apellis Pharmaceuticals reported an annual revenue of $781.37M, reflecting a 97.02% growth. For the quarter ending March 31, 2025, Apellis Pharmaceuticals generated $166.8M in revenue.
Revenue (ttm)
$781.37M
Revenue Growth
97.02%
Price / Sales Ratio
5.06
Revenue / Employee
$1.11M
Employees
705
Market Cap
2.3B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.